- Home
- UNCY vs BYFC Comparison
UNCY vs BYFC Comparison
Compare UNCY & BYFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- BYFC
- Stock Information
- Founded
- UNCY 2016
- BYFC 1946
- Country
- UNCY United States
- BYFC United States
- Employees
- UNCY N/A
- BYFC 106
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- BYFC Savings Institutions
- Sector
- UNCY Health Care
- BYFC Finance
- Exchange
- UNCY Nasdaq
- BYFC Nasdaq
- Market Cap
- UNCY 91.0M
- BYFC 74.5M
- IPO Year
- UNCY 2021
- BYFC 1996
- Fundamental
- Price
- UNCY $4.87
- BYFC $8.07
- Analyst Decision
- UNCY Strong Buy
- BYFC
- Analyst Count
- UNCY 4
- BYFC 0
- Target Price
- UNCY $63.75
- BYFC N/A
- AVG Volume (30 Days)
- UNCY 934.5K
- BYFC 10.5K
- Earning Date
- UNCY 08-13-2025
- BYFC 08-05-2025
- Dividend Yield
- UNCY N/A
- BYFC N/A
- EPS Growth
- UNCY N/A
- BYFC N/A
- EPS
- UNCY N/A
- BYFC N/A
- Revenue
- UNCY N/A
- BYFC $32,732,999.00
- Revenue This Year
- UNCY N/A
- BYFC N/A
- Revenue Next Year
- UNCY $1,458.53
- BYFC N/A
- P/E Ratio
- UNCY N/A
- BYFC N/A
- Revenue Growth
- UNCY N/A
- BYFC N/A
- 52 Week Low
- UNCY $2.02
- BYFC $4.86
- 52 Week High
- UNCY $11.00
- BYFC $9.46
- Technical
- Relative Strength Index (RSI)
- UNCY 45.55
- BYFC 63.22
- Support Level
- UNCY $4.38
- BYFC $8.04
- Resistance Level
- UNCY $4.96
- BYFC $8.28
- Average True Range (ATR)
- UNCY 0.31
- BYFC 0.26
- MACD
- UNCY 0.05
- BYFC 0.00
- Stochastic Oscillator
- UNCY 41.88
- BYFC 80.00
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About BYFC Broadway Financial Corporation
Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.